Rallybio Statistics

Total Valuation

Rallybio has a market cap or net worth of $10.42 million. The enterprise value is -$54.94 million.

Market Cap	10.42M
Enterprise Value	-54.94M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Rallybio has 41.61 million shares outstanding. The number of shares has increased by 7.66% in one year.

Current Share Class	41.61M
Shares Outstanding	41.61M
Shares Change (YoY)	+7.66%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	4.05%
Owned by Institutions (%)	29.02%
Float	19.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.14
Forward PS	n/a
PB Ratio	0.17
P/TBV Ratio	0.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.87, with a Debt / Equity ratio of 0.00.

Current Ratio	10.87
Quick Ratio	10.50
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -68.85% and return on invested capital (ROIC) is -42.46%.

Return on Equity (ROE)	-68.85%
Return on Assets (ROA)	-38.91%
Return on Invested Capital (ROIC)	-42.46%
Return on Capital Employed (ROCE)	-92.45%
Revenue Per Employee	$25,440
Profits Per Employee	-$2.31M
Employee Count	25
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -84.64% in the last 52 weeks. The beta is -1.35, so Rallybio's price volatility has been lower than the market average.

Beta (5Y)	-1.35
52-Week Price Change	-84.64%
50-Day Moving Average	0.67
200-Day Moving Average	1.00
Relative Strength Index (RSI)	20.65
Average Volume (20 Days)	176,808

Short Selling Information

The latest short interest is 345,912, so 0.83% of the outstanding shares have been sold short.

Short Interest	345,912
Short Previous Month	337,792
Short % of Shares Out	0.83%
Short % of Float	1.75%
Short Ratio (days to cover)	7.92

Income Statement

In the last 12 months, Rallybio had revenue of $636,000 and -$57.78 million in losses. Loss per share was -$1.33.

Revenue	636,000
Gross Profit	-38.87M
Operating Income	-57.20M
Pretax Income	-73.88M
Net Income	-57.78M
EBITDA	-57.07M
EBIT	-57.20M
Loss Per Share	-$1.33

Full Income Statement

Balance Sheet

The company has $65.51 million in cash and $154,000 in debt, giving a net cash position of $65.36 million or $1.57 per share.

Cash & Cash Equivalents	65.51M
Total Debt	154,000
Net Cash	65.36M
Net Cash Per Share	$1.57
Equity (Book Value)	61.65M
Book Value Per Share	1.49
Working Capital	61.60M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-49.28M
Capital Expenditures	n/a
Free Cash Flow	-49.28M
FCF Per Share	-$1.18

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-8,993.08%
Pretax Margin	-9,084.12%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Rallybio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.66%
Shareholder Yield	n/a
Earnings Yield	-554.70%
FCF Yield	-473.16%

Analyst Forecast

The average price target for Rallybio is $11.33, which is 4,426.57% higher than the current price. The consensus rating is "Buy".

Price Target	$11.33
Price Target Difference	4,426.57%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	261.73%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Rallybio has an Altman Z-Score of -2.4 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.4
Piotroski F-Score	1